A compelling session at the EHA Congress explored how space research is reshaping our understanding of hematologic processes.

First clinical data for INCA033989, a novel monoclonal antibody from Incyte (Nasdaq: INCY) targeting CALR-mutant ...

Congress, hematology experts highlight breakthroughs in treatment, the importance of patient voices, and challenges in making innovations accessible worldwide.

Sessions and posters at the 2025 European Hematology Association Congress evaluated the potential and real-world practices of using artificial intelligence (AI) to predict and improve outcomes for ...

ARV-393 demonstrated significant single-agent activity in models of nodal T-follicular helper cell lymphoma, ...

Analysts at Truist Securities called J&J’s CAR-T readout “compelling,” noting that the efficacy figures could position the ...

Positive updates across all programs, including longer term efficacy and safety data from the HELIOS open-label extension ...

Experts reassess endpoints, patient selection, targets, and timing for the development of successful immune-based treatments ...

will be presented at the European Hematology Association (EHA) 2025 Hybrid Congress, taking place June 12-15, 2025, in Milan, Italy and online. The presentation will highlight initial results from ...

The data will be shared in a poster presentation today at the European Hematology Association 2025 Congress (EHA2025) in Milan. New data from the BEACON trial with more patients and longer follow ...

Nurix Therapeutics (NRIX) stock falls as the company posts new early-stage trial data for its lead asset bexobrutideg ...

The results from these preclinical studies were shared at the European Hematology Association (EHA) 2025 Congress in Milan, Italy. Key findings from the preclinical studies included: Single-agent ...